Long Term Follow-up of the VisAbility™ Micro Insert System for Presbyopic Patients
Completed · Not applicable
Conditions studied: Presbyopia
In brief
The objective of this study is to obtain an additional 36 months of safety and effectiveness data from all subjects who were implanted with the VisAbility™ Micro Insert in the VIS-2014 clinical trial.
Key facts
- Study ID
- NCT03811249
- Run by
- Refocus Group, Inc.
- People needed
- 287
- Starts
- 2018-12-03
- Expected to finish
- 2021-10-29
- Last updated by the study team
- 2023-11-18
Who can join
Age: 45 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Subjects who were implanted with the VisAbility™ Micro Insert in Protocol VIS-2014
You may not qualify if…
- N/A
Where it is running
- Coastal Vision — Orange, California, United States
- Gordon Schanzlin New Vision Institute — San Diego, California, United States
- Aloha Laser Vision — Honolulu, Hawaii, United States
- The Midwest Center for Sight — Des Plaines, Illinois, United States
- Eye Surgeons Of Indiana PC — Indianapolis, Indiana, United States
- Eye Care Institute — Louisville, Kentucky, United States
- Chu Vision Institute — Bloomington, Minnesota, United States
- South Shore Eye Care LLP — Wantagh, New York, United States
- Physicians Protocol — Greensboro, North Carolina, United States
- Comprehensive EyeCare of Central Ohio — Westerville, Ohio, United States
- Bucci Laser Vision — Wilkes-Barre, Pennsylvania, United States
- Key Whitman Eye Center — Dallas, Texas, United States
- Braverman-Terry-Oei-Eye Associates — San Antonio, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.